The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Detlev Boison

Legacy Research Institute

1225 NE 16th Ave

Portland

OR 97202

USA

[email]@downeurobiology.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Legacy Research Institute, 1225 NE 16th Ave, Portland, OR 97202, USA. 2013
  • R.S. Dow Neurobiology Labs, Legacy Research Institute, Portland, Oregon. 2006 - 2012
  • Senior Scientist, Director, Epilepsy Program, RS Dow Neurobiology Laboratories, USA. 2011
  • NCCR Neural Plasticity and Repair, University and ETH Zurich, Zurich, Switzerland. 2007

References

  1. Adenosine kinase: exploitation for therapeutic gain. Boison, D. Pharmacol. Rev. (2013) [Pubmed]
  2. Adenosine dysfunction in epilepsy. Boison, D. Glia (2012) [Pubmed]
  3. Modulators of nucleoside metabolism in the therapy of brain diseases. Boison, D. Curr. Top. Med. Chem (2011) [Pubmed]
  4. Adenosine signaling and function in glial cells. Boison, D., Chen, J.F., Fredholm, B.B. Cell Death Differ. (2010) [Pubmed]
  5. Inhibitory RNA in epilepsy: research tools and therapeutic perspectives. Boison, D. Epilepsia (2010) [Pubmed]
  6. Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Boison, D. Neurotherapeutics (2009) [Pubmed]
  7. Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. Boison, D. Epilepsy Res. (2009) [Pubmed]
  8. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Boison, D., Stewart, K.A. Biochem. Pharmacol. (2009) [Pubmed]
  9. The adenosine kinase hypothesis of epileptogenesis. Boison, D. Prog. Neurobiol. (2008) [Pubmed]
  10. Adenosine as a neuromodulator in neurological diseases. Boison, D. Curr. Opin. Pharmacol (2008) [Pubmed]
  11. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Boison, D. Neurodegener. Dis (2007) [Pubmed]
  12. Adenosine as a modulator of brain activity. Boison, D. Drug News Perspect. (2007) [Pubmed]
  13. Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Boison, D. Trends Pharmacol. Sci. (2006) [Pubmed]
 
WikiGenes - Universities